Hopwood N J, Rabin B S, Foley T P, Peake R L
J Pediatr. 1978 Jul;93(1):57-61. doi: 10.1016/s0022-3476(78)80600-3.
Thyroid antibodies were determined by three different techniques in the sera of 125 children and adolescents with thyroid disorders and in the sera of 53 short, normal children without thyroid dysfunction. The incidence of antithyroglobulin antibodies in patients with thyroiditis was highest when measured by radioimmunoassay (85%), less than when measured by hemagglutination (24%), and least by antimicrosomal antibodies (7%). No patient who had initially negative serum for RATA subsequently had positive tests during follow-up of five to 24 months, whereas eight of 31 patients with initially negative serum for ATA later developed positive tests. Treatment appeared to have a suppressive effect on RATA, but not on ATA titers, in hypothroid patients with clinical thyroiditis. The incidence of hypothyroidism in the patients with clinical thyroiditis on initial presentation was significant (37%) and suggests that identification of children and adolescents with thyroiditis is important to ensure adequate medical follow-up.
采用三种不同技术检测了125例患有甲状腺疾病的儿童和青少年以及53例无甲状腺功能障碍的身材矮小的正常儿童血清中的甲状腺抗体。甲状腺炎患者中抗甲状腺球蛋白抗体的发生率,采用放射免疫测定法时最高(85%),采用血凝法时较低(24%),采用抗微粒体抗体法时最低(7%)。最初血清放射性甲状腺抗体测定(RATA)为阴性的患者,在5至24个月的随访期间均未出现阳性检测结果,而31例最初抗甲状腺自身抗体(ATA)血清为阴性的患者中有8例后来检测结果转为阳性。在患有临床甲状腺炎的甲状腺功能减退患者中,治疗似乎对RATA有抑制作用,但对ATA滴度无抑制作用。临床甲状腺炎患者初诊时甲状腺功能减退的发生率显著(37%),这表明识别患有甲状腺炎的儿童和青少年对于确保充分的医学随访很重要。